These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20078196)

  • 1. Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients.
    Parra S; Marsillach J; Aragonés G; Beltrán R; Montero M; Coll B; Mackness B; Mackness M; Alonso-Villaverde C; Joven J; Camps J
    J Infect Dis; 2010 Feb; 201(4):627-34. PubMed ID: 20078196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
    Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
    Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
    Najafi M; Gohari LH; Firoozrai M
    Thromb Res; 2009; 123(3):503-10. PubMed ID: 18433845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
    Jarvik GP; Hatsukami TS; Carlson C; Richter RJ; Jampsa R; Brophy VH; Margolin S; Rieder M; Nickerson D; Schellenberg GD; Heagerty PJ; Furlong CE
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1465-71. PubMed ID: 12805074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.
    Kim NS; Kang BK; Cha MH; Oh SM; Ko MM; Bang OS
    Clin Biochem; 2009 Jun; 42(9):857-63. PubMed ID: 19233151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
    J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-pathogen interactions in the development of metabolic disturbances and atherosclerosis in HIV infection: the role of CCL2 genetic variants.
    Alonso-Villaverde C; Aragonès G; Beltrán-Debón R; Fernández-Sender L; Rull A; Rodríguez-Sanabria F; Marsillach J; Pardo-Reche P; Camps J; Joven J
    Cytokine; 2010 Sep; 51(3):251-8. PubMed ID: 20573518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
    Mackness B; Quarck R; Verreth W; Mackness M; Holvoet P
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1545-50. PubMed ID: 16627808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype-phenotype relationships of paraoxonase-1.
    Chen J; Chan W; Wallenstein S; Berkowitz G; Wetmur JG
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):731-4. PubMed ID: 15767359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
    Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Roest M; Jansen AC; Barendrecht A; Leus FR; Kastelein JJ; Voorbij HA
    Clin Biochem; 2005 Feb; 38(2):123-7. PubMed ID: 15642273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.